The Use of Desirudin Versus Heparin for Thrombosis Prophylaxis in Cardiothoracic Surgery Patients.

Trial Profile

The Use of Desirudin Versus Heparin for Thrombosis Prophylaxis in Cardiothoracic Surgery Patients.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 09 Dec 2014

At a glance

  • Drugs Desirudin (Primary) ; Heparin
  • Indications Thromboembolism
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Mar 2009 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
    • 06 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 22 May 2008 Planned end date (Sep 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top